ArticleBlood advances2022

Production and nonclinical evaluation of an autologous iPSC-derived platelet product for the iPLAT1 clinical trial.

Naoshi Sugimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.